These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The prevalence of duloxetine in medico-legal death investigations in Victoria, Australia (2009-2012). Pilgrim JL; Gerostamoulos D; Drummer OH Forensic Sci Int; 2014 Jan; 234():165-73. PubMed ID: 24378318 [TBL] [Abstract][Full Text] [Related]
25. Effects of Magnesium Oxide on the Serum Duloxetine Concentration and Antidepressant-Like Effects of Duloxetine in Rats. Esumi S; Kitamura Y; Yokota-Kumasaki H; Ushio S; Yamada-Takemoto A; Nagai R; Ogawa A; Kawasaki Y; Sendo T Biol Pharm Bull; 2018; 41(11):1727-1731. PubMed ID: 30381673 [TBL] [Abstract][Full Text] [Related]
26. Block of neuronal Na+ channels by antidepressant duloxetine in a state-dependent manner. Wang SY; Calderon J; Kuo Wang G Anesthesiology; 2010 Sep; 113(3):655-65. PubMed ID: 20693878 [TBL] [Abstract][Full Text] [Related]
27. Cellular electrophysiological effects of chronic fluoxetine and duloxetine administration on serotonergic responses in the aging hippocampus. Smith JE; Lakoski JM Synapse; 1998 Nov; 30(3):318-28. PubMed ID: 9776135 [TBL] [Abstract][Full Text] [Related]
28. [Cymbalta in the treatment of chronic pain syndromes]. Odinak MM; Kashin AV; Ememlin AIu Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):32-4. PubMed ID: 19365388 [TBL] [Abstract][Full Text] [Related]
29. The safety of duloxetine during pregnancy and lactation. Andrade C J Clin Psychiatry; 2014 Dec; 75(12):e1423-7. PubMed ID: 25551238 [TBL] [Abstract][Full Text] [Related]
30. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders. Gupta S; Nihalani N; Masand P Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852 [TBL] [Abstract][Full Text] [Related]
31. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385 [TBL] [Abstract][Full Text] [Related]
35. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression. Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348 [TBL] [Abstract][Full Text] [Related]
36. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729 [TBL] [Abstract][Full Text] [Related]
37. Acute and long-term treatment of late-life major depressive disorder: duloxetine versus placebo. Robinson M; Oakes TM; Raskin J; Liu P; Shoemaker S; Nelson JC Am J Geriatr Psychiatry; 2014 Jan; 22(1):34-45. PubMed ID: 24314888 [TBL] [Abstract][Full Text] [Related]
38. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development. Montgomery S Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676 [TBL] [Abstract][Full Text] [Related]
39. A first look at duloxetine (Cymbalta) in a postmortem laboratory. Anderson D; Reed S; Lintemoot J; Kegler S; DeQuintana S; Sandberg M; Muto J J Anal Toxicol; 2006 Oct; 30(8):576-80. PubMed ID: 17132255 [TBL] [Abstract][Full Text] [Related]
40. Infant health and neurodevelopmental outcomes following prenatal exposure to duloxetine. Bellantuono C; Marini A; Lucarelli C Clin Drug Investig; 2013 Sep; 33(9):685-8. PubMed ID: 23873363 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]